A Syngeneic Mouse B-Cell Lymphoma Model for Pre-Clinical Evaluation of CD19 CAR T Cells

The astonishing clinical success of CD19 chimeric antigen receptor (CAR) T-cell therapy has led to the approval of two second generation chimeric antigen receptors (CARs) for acute lymphoblastic leukemia (ALL) andnon-Hodgkin lymphoma (NHL). The focus of the field is now on emulating these successes...

Ful tanımlama

Kaydedildi:
Detaylı Bibliyografya
Yayımlandı:J Vis Exp
Asıl Yazarlar: Kueberuwa, Gray, Zheng, Weiming, Kalaitsidou, Milena, Gilham, David E., Hawkins, Robert E.
Materyal Türü: Artigo
Dil:Inglês
Baskı/Yayın Bilgisi: MyJove Corporation 2018
Konular:
Cancer Research
Online Erişim:https://ncbi.nlm.nih.gov/pmc/articles/PMC6235544/
https://ncbi.nlm.nih.gov/pubmed/30394400
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3791/58492
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!

Benzer Materyaller